Is DFEMX or JNJ a better dividend investment in 2026?

DFEMX currently yields 2.31% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between DFEMX and JNJ?

DFEMX has a forward dividend yield of 2.31% ($0.89/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1.05 percentage points.

Home › Compare › DFEMX vs JNJ

DFEMX vs JNJ: Dividend Comparison 2026

DFEMX yields 2.31% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DFEMX wins by $3.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DFEMX

● Live price

2.31%

Share price

$38.43

Annual div

$0.89

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.1K

Annual income

$268.65

Full DFEMX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — DFEMX vs JNJ

📍 DFEMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DFEMX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DFEMX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DFEMX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DFEMX

Annual income on $10K today (after 15% tax)

$196.65/yr

After 10yr DRIP, annual income (after tax)

$228.35/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $475.26/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DFEMX + JNJ for your $10,000?

DFEMX: 50%JNJ: 50%

100% JNJ50/50100% DFEMX

Portfolio after 10yr

$21.6K

Annual income

$548.21/yr

Blended yield

2.54%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DFEMX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DFEMX buys

JNJ buys

No recent congressional trades found for DFEMX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDFEMXJNJ

Forward yield	2.31%	3.36% ✓
Annual dividend / share	$0.89	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$23.1K ✓	$20.0K
Annual income after 10y	$268.65	$827.78 ✓
Total dividends collected	$2.5K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DFEMX vs JNJ ($10,000, DRIP)

Year	DFEMX Portfolio	DFEMX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$10,931	$231.35	$10,676	$355.77	+$255.00 → DFEMX
2	$11,933	$236.36	$11,407	$389.39	+$526.00 → DFEMX
3	$13,009	$241.13	$12,198	$426.53	+$811.00 → DFEMX
4	$14,166	$245.69	$13,056	$467.62	+$1.1K → DFEMX
5	$15,407	$250.02	$13,987	$513.12	+$1.4K → DFEMX
6	$16,740	$254.15	$14,998	$563.56	+$1.7K → DFEMX
7	$18,170	$258.06	$16,098	$619.52	+$2.1K → DFEMX
8	$19,703	$261.78	$17,295	$681.69	+$2.4K → DFEMX
9	$21,348	$265.31	$18,599	$750.82	+$2.7K → DFEMX
10	$23,111	$268.65	$20,022	$827.78	+$3.1K → DFEMX

DFEMX vs JNJ: Complete Analysis 2026

DFEMX — Stock

The Portfolio is a Feeder Portfolio and pursues its objective by investing substantially all of its assets in its corresponding master fund, the Emerging Markets Series (the “Emerging Markets Series” or the “Series”) of the DFA Investment Trust Company (the "Trust"), which has the same investment objective and policies as the Portfolio. As a non-fundamental policy, under normal circumstances, the Emerging Markets Series will invest at least 80% of its net assets in emerging markets investments that are defined in the Prospectus as Approved Market securities.

Full DFEMX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this DFEMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DFEMX vs SCHD DFEMX vs JEPI DFEMX vs O DFEMX vs KO DFEMX vs MAIN DFEMX vs ABBV DFEMX vs MRK DFEMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.